1/5
Export Ready

REMTREX 2.5MG, 15MG,

Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Values shown are for melizza lifescience.
Compliance & Certifications
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.

Rajkot Dispatch on request Verified seller
melizza lifescience logo

melizza lifescience

Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
Not shared
Employees
–
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
GlobalLinker Member Since
Aug 2025
Turnover
Incorporation Type
On request
Verified Seller
Product details

What are the specifications of this product?

Overview

Product Name: Capeta Nova 500mg Tablet Generic Name: Capecitabine 500 mg Manufacturer: Nova (Capeta Nova brand) Therapeutic Category:Oncology / Antimetabolite Chemotherapy Product Description: Capeta Nova 500mg contains Capecitabine, an oral fluoropyrimidine carbamate that acts as a prodrug of 5-Fluorouracil (5-FU). It is specifically designed to be activated in tumor tissues, minimizing systemic toxicity and enhancing anticancer activity. Capecitabine interferes with DNA synthesis in rapidly dividing cancer cells, leading to their death. Indications: • Colorectal Cancer (adjuvant and metastatic) • Breast Cancer (metastatic, resistant to paclitaxel/anthracycline regimens) • Gastric Cancer (advanced/metastatic) • Used as monotherapy or in combination regimens with other chemotherapeutic agents

Product Description

Mechanism of Action:

• Capecitabine is converted enzymatically into 5-FU within tumor cells.

• 5-FU inhibits thymidylate synthase, preventing DNA replication and cell division.

• Selective activation in tumor tissue reduces systemic toxicity compared to direct 5-FU therapy.


Dosage & Administration:

• Typical dose: 1250 mg/m² orally twice daily for 14 days, followed by 7 days rest (21-day cycle).

• Dose adjustments are based on toxicity and patient condition.

• Tablets should be swallowed with water within 30 minutes after a meal.

(Only to be prescribed and supervised by an oncologist.)


Key Benefits:

• Oral chemotherapy – no hospitalization required.

• Tumor-targeted activation for better safety profile.

• Effective in multiple solid tumors including breast, colon, and gastric cancers.


Packaging:

• Box of 120 tablets (500 mg each)

• Also available in 150 mg strength (varies by brand/market)


Storage:

• Store below 25°C, in a dry place.

• Protect from light and moisture.


Important Notes:

• For oncology use only.

• Side effects may include hand-foot syndrome, diarrhea, nausea, fatigue.

• Dose modification required in renal impairment.

• Contraindicated in pregnancy and breastfeeding.


Description provided by melizza lifescience.

Specifications

Generic Name Capecitabine
Brand Name Capeta Nova
Strength 500 mg per tablet
Tablet Count 120 tablets per box
Chemical Class Oral fluoropyrimidine carbamate
Route of Administration Oral
Pharmacological Action Antimetabolite chemotherapy agent
Contraindications Pregnancy, breastfeeding
Common Side Effects Hand-foot syndrome, diarrhea, nausea, fatigue
Dose Adjustment Required in renal impairment
Manufacturer Nova

Use cases

Category Pharmaceuticals > Oncology Drugs > Antimetabolite Chemotherapy Agents
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing REMTREX 2.5MG, 15MG,. Answers compiled from verified sellers' commercial terms and platform data.

Q: How does Capeta Nova 500mg minimize systemic toxicity compared to direct 5-FU administration?
A: Capeta Nova contains Capecitabine, a prodrug enzymatically converted to 5-FU selectively within tumor tissues, which reduces systemic exposure and lowers toxicity compared to direct intravenous 5-FU.
Q: Can Capeta Nova 500mg be used for combination chemotherapy regimens?
A: Yes, Capeta Nova can be used alone or combined with other chemotherapeutic agents for enhanced efficacy against solid tumors like colorectal and gastric cancers.
Q: What are the specific storage requirements to maintain Capeta Nova tablet potency?
A: The tablets must be stored below 25°C in a dry place, protected from light and moisture to preserve stability and effectiveness.
Q: Is dose adjustment necessary for patients with renal impairment?
A: Yes, renal impairment requires careful dose modification to avoid increased toxicity while maintaining optimal therapeutic effect.
Q: What precautions should be followed regarding pregnancy and breastfeeding when administering Capeta Nova?
A: Capeta Nova is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus and infant; it should only be used under strict medical supervision.
Q: What is the recommended administration schedule for Capeta Nova 500mg tablets?
A: Typically, 1250 mg/m² is taken orally twice daily for 14 days followed by a 7-day rest, forming a 21-day treatment cycle, always under oncologist supervision.
Question not answered? Ask sellers directly — typical response within 4 hours.

What similar products are available in this category?

Browse all in category
View all →
erlocip 150mg
erlocip 150mg
Price on request MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
Price on request MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
Price on request MOQ 1 Centimetre
View Product
altanib nova imatinib 400mg tablets
altanib nova imatinib 400mg tablets
Price on request MOQ 1 Centimetre
View Product
lucrin depot 3.75 mg / 11.25 mg injection
lucrin depot 3.75 mg / 11.25 mg injection
Price on request MOQ 1 Centimetre
View Product
truvada-tablets
truvada-tablets
Price on request MOQ 1 Centimetre
View Product
abstet 250mg tablet (abiraterone acetate (250mg))
abstet 250mg tablet (abiraterone acetate (250mg))
Price on request MOQ 1 Piece
View Product
syringe glycerine
syringe glycerine
Price on request MOQ 1 Centimetre
View Product
REMTREX 2.5MG, 15MG,
REMTREX 2.5MG, 15MG,
Price on request · MOQ 1Centimetre